Press Releases 2016
Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System - Sep 19, 2016
Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the LOTUS Edge™ Valve System, the company's next generation transcatheter aortic valve implantation (TAVI) technology.
Boston Scientific announces new data from the RESPOND study of the LOTUS™ Valve presented today at EuroPCR2016
May 17, 2016
Outcomes from this post market study of more than 1,000-patients demonstrate the safety and efficacy of transcatheter aortic valve implantation (TAVI) with the LOTUS™ Valve in routine clinical practice.